Insilico Medicine’s AI-designed TEAD inhibitor ISM6331 shows 18.2% response rate in mesothelioma patients, with 68.2% achieving disease control in early trials.
AI enhances brain aneurysm detection by 39% but increases false alarms, offering a second set of eyes for radiologists.
Medicare prior-authorization pilot survives Senate Republican vote, keeping AI-driven checks in six states as Democrats fail to end the program.
Discover how AI boosts healthcare connectivity and streamlines clinician workflows for better patient care.
BD's Muhsin discusses connected care AI to help medical staff monitor hospital patients and manage medications, advancing data-driven healthcare.